Public funding for science is critical to the development of promising technologies and products. Highly targeted funding of areas of science, like what is being done in France with climate change, are integral in making rapid progress in those areas. The US has many programs similar to the one highlighted by France; such as the cancer moonshot seeking to make progress quicker on cancer prevention, detection and treatment; the BRAIN initiative seeking to treat, cure, and prevent brain disorders, the CRAN initiative focusing on addition; and the precision medicine initiative, among many other successful programs in the past. It may appear to be a significant win for science with the House of Representatives rejecting President Trump’s proposed 18% reduction in the NIH budget; However, the reality is that the new budget proposed by the house will only increase the NIH budget by 3.2%. My hope is that the minor increase in funding combined with the presidents vision of a more efficient and less wasteful government will lead to more innovations within the NIH framework. Here, it is important for the long term success of science and research public programs to place everything into context; such as the France initiative where they are creating this fund for climate change, but at the same time significantly reducing their overall science and research budget. So my final opinion is that it is great that the US House of representatives and the world supports scientific research, however, we need to continuously market and publicize scientific measures of success and why the scientific community affects the US and the global economy through these successes. This in turn will continue to build confidence in scientific funding.